Here is Matt Lowdon‘s weekly medtech, deeptech, and biotech funding summary. Headlines include updates across energy intel, AI DD, neurotech and more.
🔔 Dimerix Limited snaps up Mission Therapeutics’s phase 2-ready kidney disease candidate in $292M deal.
🔔 The British Business Bank commits £21m to EQT Group Life Sciences’ Health Economics 3 Fund to support scaling medical technology and digital health companies.
🔔 Spirit Health raises £2m from Midlands Engine Investment Fund II
🔔 Gaussion, the London-based deep tech company pioneering energy intelligence technology for battery packs, has secured a $28m investment round.
🔔 Orakl Oncology has secured exclusive rights to four undisclosed oncology assets from Sanofi, giving the startup an opportunity to test whether its combination of patient-derived tumour models and artificial intelligence can improve drug development decisions.
🔔 BIOTRONIK Neuro snaps up spinal cord stimulation portfolio from SOIN NEUROSCIENCE, INC. for next-gen pain project
🔔 Resmed to sell MatrixCare for $490M to private equity firm
🔔 Cambridge-based agtech startup Dogtooth Technologies has secured over £14m in growth capital to scale the commercial deployment of its AI-powered fruit-harvesting robots.
🔔 Chai Discovery brews up $400M series C to fuel AI molecule models used by Lilly, Novartis and Pfizer
🔔 Spanish investment holding company CriteriaCaixa plans to invest €300m in early-stage biotechnology and technology companies by 2030
🔔 Austria’s GraphTx has raised $5m in new financing, bringing its total funding to more than $10m as it advances internal drug discovery programmes in inflammation and immunology built on its AI-enabled platform.
🔔 Swedish biotech PharmNovo has raised about SEK39m to help finance a phase 2 study of PN6047, its experimental treatment for neuropathic pain.
🔔 Alchemab Therapeutics Ltd extends Series A with £25m from British Business Bank
🔔 Avere Therapeutics goes public via NextCure reverse merger, secures Hansoh IL-23 drug with $2.3B deal
🔔 Welsh biotech Draig Therapeutics has raised an oversubscribed $65 million Series B to accelerate its neuropsychiatry pipeline, taking its total funding to $205 million
🔔 Global investment giant KKR has launched Allyntra, a new precision-engineered solutions platform for the medtech industry, and announced several senior management changes.
🔔 Lilly buys AtaiBeckley for $2.8B upfront to challenge J&J for psychedelic mental health market
Congratulations to all involved.